Full Text
Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey

Abstract

Authors

M. Tatar S. Sezen A. Senturk M.M. Balp M. Saylan A. Keskinaslan

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×